Abstract
Eeyarestatin 1 (ES1) is an inhibitor of endoplasmic reticulum (ER) associated protein degradation, Sec61-dependent Ca2+ homeostasis and protein translocation into the ER. Recently, evidence was presented showing that a smaller analog of ES1, ES24, targets the Sec61-translocon, and captures it in an open conformation that is translocation-incompetent. We now show that ES24 impairs protein secretion and membrane protein insertion in Escherichia coli via the homologous SecYEG-translocon. Transcriptomic analysis suggested that ES24 has a complex mode of action, probably involving multiple targets. Interestingly, ES24 shows antibacterial activity toward clinically relevant strains. Furthermore, the antibacterial activity of ES24 is equivalent to or better than that of nitrofurantoin, a known antibiotic that, although structurally similar to ES24, does not interfere with SecYEG-dependent protein trafficking. Like nitrofurantoin, we find that ES24 requires activation by the NfsA and NfsB nitroreductases, suggesting that the formation of highly reactive nitroso intermediates is essential for target inactivation in vivo.
| Original language | English |
|---|---|
| Article number | 32798330 |
| Pages (from-to) | 28-40 |
| Number of pages | 13 |
| Journal | Molecular Microbiology |
| Volume | 115 |
| Issue number | 1 |
| Early online date | 15 Aug 2020 |
| DOIs | |
| Publication status | Published - Jan 2021 |
Funding
This study was supported by the NWO graduate program (022.005.031) awarded to MS, the German Science Foundation (grant SPP2002/KO2184/9-1, grant KO2184/8) and Project-ID 403222702/SFB 1381 awarded to HGK and by a Wellcome Trust Investigator Award in Science (204957/Z/16/Z) awarded to SH. We thank Karin van Dijk (Amsterdam UMC, VU University), Juan L. Ramos (Estaci?n Experimental del Zaidin) and Dan I. Andersson (Uppsala University) for kindly providing E. coli strains resistant to nitrofurantoin. We also thank Helen I. Zgurskaya (University of Oklahoma) for providing the E. coli FhuA ?C/?4L strain. In addition, we thank Peter van Ulsen for critically reading the manuscript and for valuable input in the project. This study was supported by the NWO graduate program (022.005.031) awarded to MS, the German Science Foundation (grant SPP2002/KO2184/9‐1, grant KO2184/8) and Project‐ID 403222702/SFB 1381 awarded to HGK and by a Wellcome Trust Investigator Award in Science (204957/Z/16/Z) awarded to SH.
| Funders | Funder number |
|---|---|
| University of Oklahoma | |
| Uppsala Universitet | |
| Wellcome Trust | 204957/Z/16/Z |
| Deutsche Forschungsgemeinschaft | Project‐ID 403222702/SFB 1381, SPP2002/KO2184/9‐1, KO2184/8 |
| NWO | 022.005.031 |
Keywords
- eeyarestatin 1
- Escherichia coli
- nitrofurantoin
- Sec61
Fingerprint
Dive into the research topics of 'Eeyarestatin 24 impairs SecYEG-dependent protein trafficking and inhibits growth of clinically relevant pathogens'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver